Hyun Ryoung Kim

Title: The Innovative Contributions of Hyun Ryoung Kim

Introduction

Hyun Ryoung Kim is a notable inventor based in Guri-si, South Korea. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of advanced liposome formulations. With a total of 3 patents to his name, Kim's work is paving the way for innovative drug delivery systems.

Latest Patents

One of Kim's latest patents is titled "Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof." This invention focuses on a liposome that includes an elastin-like polypeptide (ELP) and a tumor cell targeting material. It also encompasses a pharmaceutical composition that utilizes this liposome and a method for delivering an active agent to a target site using the liposome.

Another significant patent is "Sonosensitive liposome, pharmaceutical composition including the same, and method of delivering active agent to subject using the sonosensitive liposome." This invention describes a liposome that comprises a lipid bilayer and a sonosensitizer. The sonosensitizer self-assembles to form aggregates when exposed to ultrasound, allowing for efficient delivery of an active agent to a target site in the body.

Career Highlights

Hyun Ryoung Kim is currently employed at Samsung Electronics Co., Ltd., where he continues to innovate and develop new technologies. His work at this leading company has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of Kim's notable coworkers include Sun Min Park and Jungyong Nam. Their collaborative efforts contribute to the advancement of research and development in pharmaceutical technologies.

Conclusion

Hyun Ryoung Kim's innovative work in liposome technology demonstrates his commitment to improving drug delivery systems. His patents reflect a deep understanding of pharmaceutical applications and a drive to enhance treatment options for patients.